SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
نویسندگان
چکیده
Abstract In order to support vaccine development, and aid convalescent plasma therapy, it would be important understand the kinetics, timing persistence of SARS-CoV-2 neutralizing antibodies (NAbs), their association with clinical disease severity. Therefore, we used a surrogate viral neutralization test evaluate levels in patients varying severity illness, those prolonged shedding mild/asymptomatic illness at various time points. Patients severe or moderate COVID-19 had earlier appearance NAbs higher compared mild asymptomatic illness. Furthermore, who virus, appearing faster than cleared virus earlier. During first week NAb was significantly less (p = 0.01), At end 4 weeks (28 days), although 89% NAbs, 38/76 (50%) > 90 days negative result for presence NAbs. The Ab declined during convalescence (> since onset illness), 8 Our data show that high early associated these 50% individuals after 3 months
منابع مشابه
Gastrointestinal Manifestations in Patients Infected with SARS-CoV-2
Coronavirus disease 2019, caused by severe acute respiratory syndrome coronavirus 2, has recently become the number one problem affecting global health. Coronavirus disease 2019 is principally recognized by its respiratory manifestations; however, recent studies have shown an increasing number of patients with gastrointestinal complaints like diarrhea, nausea, vomiting, and abdominal discomfort...
متن کاملCHALLENGES OF LABORATORY SAMPLING AND DIAGNOSIS OF SARS-COV-2 VIRUS OF DISEASE (COVID-19)
Background & Aims: Given the prevalence of SARS-CoV-2 worldwide, it is essential to identify people infected with the virus and determine its different types to control the global outbreak of COVID-19. The results of the studies are controversial, so this study examines these diagnostic challenges, including the types of diagnostic methods, the type and time of sampling, and even the clinical c...
متن کاملA review of coronaviruses focusing on SARS-CoV-2 (2019-nCoV) the cause of COVID-19
Coronaviruses, enveloped positive single-stranded RNA viruses, have become significant pathogens for humans and other vertebrates since the outbreak of SARS (severe acute respiratory syndrome) in 2002 in China. These viruses could infect the respiratory tract of humans and other animals. The outbreaks of SARS and MERS (Middle East respiratory syndrome), which Bats are thought to be the origin o...
متن کاملThe changes of Coagulation State in Patients Contracted with SARS-COV-19
Coronaviruses are considered to be one of the most significant human and animal pathogens. In late 2019, a new species of coronavirus was recognized as the cause of some pneumonia cases in Wuhan, China. The disease spread rapidly and made an epidemic in China and subsequently in almost all countries in the world. I...
متن کاملCOVID-19: a hypothesis to prevent SARS-CoV-2 from entering respiratory cells
Coronaviruses (CoVs) are a group of viruses that induce infection in the respiratory and other systems in the human body. There are two coronaviruses that transmitted from animals to humans including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) (1). The novel coronavirus that appeared at first in Wuhan, China, in December 2019 was named as severe acut...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Scientific Reports
سال: 2021
ISSN: ['2045-2322']
DOI: https://doi.org/10.1038/s41598-021-81629-2